<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101671285</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry Cogn Neurosci Neuroimaging</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol Psychiatry Cogn Neurosci Neuroimaging</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry. Cognitive neuroscience and neuroimaging</journal-title>
</journal-title-group>
<issn pub-type="ppub">2451-9022</issn>
<issn pub-type="epub">2451-9030</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29703679</article-id>
<article-id pub-id-type="pmc">6986924</article-id>
<article-id pub-id-type="manuscript">EMS85458</article-id>
<article-id pub-id-type="doi">10.1016/j.bpsc.2018.03.003</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Network Neuroscience Approach to Typical and Atypical Brain Development</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Morgan</surname>
<given-names>Sarah E.</given-names>
</name>
<aff id="A1">Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>White</surname>
<given-names>Simon R.</given-names>
</name>
<aff id="A2">Department of Psychiatry, University of Cambridge, Cambridge; MRC Biostatistics Unit, University of Cambridge, Cambridge</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bullmore</surname>
<given-names>Edward T.</given-names>
</name>
<aff id="A3">Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge; Cambridgeshire and Peterborough NHS Foundation Trust, Huntingdon; ImmunoPsychiatry, Immuno-Inflammation Therapeutic Area Unit, GlaxoSmithKline R&amp;D, Stevenage, United Kingdom</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>VÃ©rtes</surname>
<given-names>Petra E.</given-names>
</name>
<aff id="A4">Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="CR1">Address correspondence to Sarah E. Morgan, Ph.D., Behavioural and Clinical Neuroscience Institute, Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, UK; <email>sem91@cam.ac.uk</email>.</corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P34">
<bold>Disclosures</bold>
</p>
<p id="P35">ETB is employed half-time by the University of Cambridge and half-time by GlaxoSmithKline; he holds stock in GlaxoSmithKline. The other authors report no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>3</volume>
<issue>9</issue>
<fpage>754</fpage>
<lpage>766</lpage>
<!--elocation-id from pubmed: 10.1016/j.bpsc.2018.03.003-->
<abstract>
<p id="P1">Human brain networks based on neuroimaging data have already proven useful in characterizing both normal and abnormal brain structure and function. However, many brain disorders are neurodevelopmental in origin, highlighting the need to go beyond characterizing brain organization in terms of static networks. Here, we review the fast-growing literature shedding light on developmental changes in network phenotypes. We begin with an overview of recent large-scale efforts to map healthy brain development, and we describe the key role played by longitudinal data including repeated measurements over a long period of follow-up. We also discuss the subtle ways in which healthy brain network development can inform our understanding of disorders, including work bridging the gap between macroscopic neuroimaging results and the microscopic level. Finally, we turn to studies of three specific neurodevelopmental disorders that first manifest primarily in childhood and adolescence/early adulthood, namely psychotic disorders, attention-deficit/hyperactivity disorder, and autism spectrum disorder. In each case we discuss recent progress in understanding the atypical features of brain network development associated with the disorder, and we conclude the review with some suggestions for future directions.</p>
</abstract>
<kwd-group>
<kwd>ADHD</kwd>
<kwd>Autism spectrum disorder</kwd>
<kwd>Development</kwd>
<kwd>MRI</kwd>
<kwd>Network neuroscience</kwd>
<kwd>Schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>